Analytical Data
-
Gene name
ABHD18
- Application
-
Alternative Names
ABHD18; C4orf29Protein ABHD18; Alpha/beta hydrolase domain-containing protein 18; Abhydrolase domain-containing protein 18
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q0P651
-
Expression Region
25-414aa
-
Molecular Weight
60.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ABHD18 (Alpha/Betahydrolase Domain Containing 18) is a member of the alpha/beta hydrolase superfamily, which is known for its roles in lipid metabolism and signaling pathways. Understanding ABHD18 is increasingly important due to its potential implications in various health disorders, including metabolic diseases and neurodegenerative conditions. Research has revealed that ABHD18 may influence the regulation of bioactive lipids, such as endocannabinoids and fatty acids, thereby playing a crucial role in cellular signaling and homeostasis. The recombinant expression of ABHD18 in heterologous systems enables researchers to investigate its enzymatic activity, substrate specificity, and interaction with regulatory proteins. Additionally, studying ABHD18 can provide insights into its structure-function relationship and its role in modulating physiological processes. The characterization of ABHD18 through recombinant protein techniques could unveil new therapeutic targets for drug development, particularly in conditions where lipid dysregulation is a key factor. Moreover, given the emerging evidence linking ABHD18 to inflammatory responses and neuroprotective mechanisms, further research could contribute to the understanding of its role in maintaining cellular health and its potential as a novel biomarker in disease contexts. Overall, the investigation of ABHD18 recombinant protein holds promise for advancing our knowledge of lipid biology and its associated implications in health and disease.
